Revvity, Inc. (LON:0KHE)
92.75
-1.92 (-2.03%)
At close: Apr 17, 2025
Revvity Revenue
In the year 2024, Revvity had annual revenue of $2.76B USD with 0.16% growth. Revvity had revenue of $729.37M in the quarter ending December 29, 2024, with 4.81% growth.
Revenue
$2.76B
Revenue Growth
+0.16%
P/S Ratio
3.87
Revenue / Employee
$250.46K
Employees
11,000
Market Cap
8.47B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Revvity News
- 21 days ago - Revvity to Hold Earnings Call on Monday, April 28, 2025 - Business Wire
- 22 days ago - What's Going On With Revvity Stock Today? - Benzinga
- 22 days ago - Revvity gets FDA nod for its automated tuberculosis test - Seeking Alpha
- 22 days ago - Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test - Business Wire
- 22 days ago - Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery - Business Wire
- 4 weeks ago - Is Revvity Gaining or Losing Market Support? - Benzinga
- 4 weeks ago - Maryland Rep. April McClain Delaney Sold Over $54K Worth of A.O. Smith Stock: Here's What You Should Know - Benzinga
- 5 weeks ago - Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England - Business Wire